MedTrace Logo

The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia

NCT07017881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-06-12

No results posted yet for this study

Summary

This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. The research was conducted with 48 schizophrenia patients (Experimental: 24, Control: 24) registered in the Mental Health and Diseases Outpatient Clinic of a hospital. Personal Information Form, Subjective Recovery Assessment Scale, Rosenberg Self-Esteem Scale, Quality of Life Scale for Schizophrenia Patients were used to collect data. Data were collected by the researcher using the self-reporting face-to-face interview method in the form of pre-test and post-test. Psychosocial Skills Training was applied to the patients in the experimental group, one session per week, two days a week for 11 weeks, while the patients in the control group did not receive any intervention.

Conditions

  • Schizophenia Disorder
  • Psychiatric Nursing
  • Psychosocial Skills Training

Interventions

BEHAVIORAL

Psychosocial Skills Training

The 24-person intervention group was divided into three separate groups of 8 people (Group 1, Group 2, Group 3). Group 1 and Group 2 attended sessions on Tuesdays at different times, while Group 3 attended sessions on Thursdays. Psychosocial Skills Training consisted of eleven sessions in total, one session per week. Sessions lasted an average of 60 minutes for each group. In each session, 5-10 minute breaks were given for rest and eating and drinking, considering the attention span and fatigue of the patients. Psychosocial Skills Training was applied two days a week (Group 1-2: Tuesday, Group 3: Thursday) in order to ensure that the patients could get more benefit from the application.

Sponsors & Collaborators

  • Selçuk University

    collaborator UNKNOWN

  • Neslihan Lok

    lead OTHER

Principal Investigators

  • Neslihan LÖK, Prof. Dr. · Selcuk University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2024-08-09
Completion
2024-10-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07017881 on ClinicalTrials.gov